
Drug Discovery
Rule Breakers: Cyclic Peptide Landscape Webinar Recap
A CAS webinar recap on what data from 46,574 cyclic peptides shows and how Merck made enlicitide, the first oral PCSK9 inhibitor, at commercial scale.
Read the reportRead the articleDownload the summarySee the infographicRead the publicationRead the recapWatch the video

















